# Yijing Capital

> Yijing Capital is a VC fund in Shanghai backing Health Care and Biotechnology. See 45 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 45
- Last investment: Mar 2026
- Lead investor: 31%
- Last updated: Aug 2026
- Website: http://yijingcapital.com/

Yijing Capital is an investment company focuses on the medical and health-care sector. Shanghai Yijing Investment Co. Ltd. was founded in 2015 as a sister company of Yizhou Group, which is among China’s Top 500 companies and has accumulated decades of experience in multiple industries. Yijing owns multiple investment platforms, undertaking equityinvestment with both self-owned and externally sourced funds. Yijing is positioned as a professional investment company with global footprint. The Yijing core team is equipped with years of operational and managerial expertise both at home and abroad.They mainly invest in industries with high growth potential. Currently, they have completed a dozen of investment projects domestically and internationally, covering sectors including smart manufacturing, medical and health-care, AI, new retail, education and new energy. Their investment will focus more on the medical and health-care sector, and also smart manufacturing. Most companies they have invested in are growing robustly and some have gone public, and they also have exited some companies with robust return.

## Contacts

5 contacts available for Yijing Capital. Shizune tracks 1 team members at Yijing Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/yijing-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $14M–$52M |
| Series B | $7.2M–$40M |
| Series C | $11M–$210M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 12 | 27% |
| Biotechnology | 9 | 20% |
| Medical | 7 | 16% |
| Manufacturing | 7 | 16% |
| Hardware | 5 | 11% |

49 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 14 | 31% |
| Series A | 11 | 24% |
| Series C | 6 | 13% |
| Seed | 5 | 11% |
| Venture - Series Unknown | 3 | 7% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 33 | 73% |
| United States | 4 | 9% |
| Belgium | 1 | 2% |
| Singapore | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jianqun Zhang | Chairman & Founder | 4 | https://shizune.co/investors/profile/jianqun-zhang |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Maibozhixing | MaiboZhixing is an innovative company focused on antibody drug development and dedicated to developing next-generation antibody therapies for the treatment of inflammatory and autoimmune diseases. | $14.5M | Angel | Mar 23, 2026 |  |
| Rankyee Technology | Rankyee Technology is a supplier of simulations that develops next-generation computational fluid dynamics solutions with grid generation technology. |  | Series A | Mar 04, 2026 |  |
| Qiaojie Digital | Qiaojie Digital is a robotics company that specializes in the development of solutions for humanoid robots and quadruped robots. |  | Venture - Series Unknown | Feb 28, 2026 |  |
| Fortitude Biomedicines | Fortitude Biomedicines is a biotechnology company that develops antibody-based biologic drugs targeting autoimmune diseases. | $13M | Seed | Jan 26, 2026 |  |
| Noah AI | Noah AI is a research platform that generates reports quickly, reducing the time spent on research tasks. It integrates with tools like Google Drive and Notion, allowing users to work across documents, spreadsheets, and presentations. The platform provides access to a database of investment research reports and drug pipeline entries. This supportsusers in making informed decisions in the healthcare sector. |  | Series A | Dec 15, 2025 |  |
| Lightelligence | Lightelligence is the global optical computing innovator at the center of conceiving and creating technology that redefines what’s possible. With a focus on real-world solutions and a collaborative, global perspective, we’re transforming cutting edge thinking into world-changing breakthroughs. Driven by an open and transparent culture of disruptivethinkers and imaginative doers, we’re leading the way in developing workable photonic solutions that will deliver orders of magnitude more speed in computing, and positive impact on life. | $210.4M | Series C | Sep 04, 2025 |  |
| Jiangci Electronics | Jiangci Electronics is a manufacturer of high-performance piezoelectric ceramics and components. |  | Seed | Sep 02, 2025 |  |
| Noah AI | Noah AI is a research platform that generates reports quickly, reducing the time spent on research tasks. It integrates with tools like Google Drive and Notion, allowing users to work across documents, spreadsheets, and presentations. The platform provides access to a database of investment research reports and drug pipeline entries. This supportsusers in making informed decisions in the healthcare sector. |  | Series A | Aug 20, 2025 |  |
| Qiaojie Digital | Qiaojie Digital is a robotics company that specializes in the development of solutions for humanoid robots and quadruped robots. |  | Seed | Aug 06, 2025 |  |
| Mingxin Digital | Mingxin Digital is a financial technology company dedicated to driving industrial credit management with digital technology. | $27.9M | Series B | Jun 26, 2025 |  |

10 of 45 investments shown.

## Co-investors
- [Gaorong Capital](https://shizune.co/investors/profile/banyan-capital) — VC Fund, 3 deals together
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund, 3 deals together
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 3 deals together
- [Sinovation Ventures](https://shizune.co/investors/profile/sinovation-ventures) — VC Fund, 3 deals together
- [3E Bioventures](https://shizune.co/investors/profile/3e-bioventures) — VC Fund, 2 deals together
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Seeds Capital](https://shizune.co/investors/profile/seeds-capital) — VC Fund
- [Wavemaker Ventures](https://shizune.co/investors/profile/wavemaker-partners) — VC Fund

## Featured in investor lists
- [Manufacturing Investors in Singapore](https://shizune.co/investors/manufacturing-investors-singapore)
- [Manufacturing VC Funds in Singapore](https://shizune.co/investors/manufacturing-vc-funds-singapore)

## FAQ

### What does Yijing Capital invest in?

Yijing Capital invests primarily in Health Care, Biotechnology and Medical startups, most often at Series B and Series A stage. Most of the 45 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Yijing Capital's check size?

Yijing Capital typically joins rounds of $14M–$52M at Series A, $7.2M–$40M at Series B and $11M–$210M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Yijing Capital participates in.

### How do I contact Yijing Capital?

Public channels for Yijing Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Yijing Capital?

The team at Yijing Capital includes Jianqun Zhang (Chairman & Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co